Federal health advisers have voted overwhelmingly against recommending approval of an experimental treatment for Lou Gehrig's ...

Federal health advisors voted 17-1 against an experimental treatment for Lou Gehrig's disease dubbed NurOwn, although the FDA ...

CLEVELAND, Ohio (Ivanhoe Newswire) – More than six million Americans are living with Alzheimer’s disease, it slowly steals ...

A panel of independent experts on Wednesday recommended the FDA reject an experimental ALS drug developed by the biotech BrainStorm Cell Therapeutics, marking another defeat for the long embattled ...

There is no cure yet, but now, a newly FDA-approved drug is helping to slow its progression before it’s too late.

Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 JST Share Tweet list Print This image provided by Eisai in January 2023 shows vials and packaging for ...

"FDA is the 800-pound gorilla here and if they're convinced that the drug doesn't work it's very hard to change their minds," ...

Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.

Commissions we earn from partner links on this page do not affect our opinions or evaluations. Our editorial content is based on thorough research and guidance from the Forbes Health Advisory Board.

The FDA also gave full approval to a drug called Leqembi, which slowed Alzheimer’s patients’ functional and cognitive decline by 27% over 18 months, according to trial data.

In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options. The approvals ...